Help guide our efforts to modernize
Send us your comments by March 14, 2020. Menu
Trial record 8 of 35 for:    fop

An Efficacy and Safety Study of Palovarotene for the Treatment of FOP

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03312634
Recruitment Status : Active, not recruiting
First Posted : October 18, 2017
Last Update Posted : December 5, 2019
Information provided by (Responsible Party):
Clementia Pharmaceuticals Inc.